Seeking Alpha

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I...

ThinkEquity feels Regeneron (REGN +0.4%) will move higher over near-term, saying the Phase I data of its REGN727 for cholesterol management was "impressive." The firm expects its presentation of additional data this weekend to boost the stock further, and reiterates its Buy rating on the shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs